Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Windtree Therapeutics Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q1 2022
- Shares held
- 1.60M
- +60.0K (+3.9%) vs. Q1 2022
- Total value
- $664.4K
- −$1.09M (−62.2%) vs. Q1 2022
- New holders
- 2
- 9 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WINT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 5 | $8.75K |
| Q1 2025 | 5 | $57.0K |
| Q4 2024 | 15 | $108.7K |
| Q3 2024 | 8 | $389.7K |
| Q2 2024 | 5 | $4.87K |
| Q1 2024 | 9 | $238.8K |
| Q4 2023 | 12 | $194.1K |
| Q3 2023 | 12 | $197.7K |
| Q2 2023 | 12 | $151.7K |
| Q1 2023 | 9 | $12.8K |
| Q4 2022 | 27 | $276.6K |
| Q3 2022 | 27 | $518.7K |
| Q2 2022 | 25 | $664.4K |
| Q1 2022 | 27 | $1.76M |
| Q4 2021 | 26 | $2.72M |
| Q3 2021 | 19 | $3.02M |
| Q2 2021 | 27 | $3.94M |
| Q1 2021 | 21 | $2.72M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Windtree Therapeutics Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 14 | $0 | 0.00% | −2,513−99.4% | Reduced |
| Wells Fargo & Company | 1,274 | $0 | 0.00% | +12+1.0% | Added |
| Blue Bell Private Wealth Management, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Gradient Investments LLC | 23 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 2,000 | $834 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 3,673 | $1.00K | 0.00% | +633+20.8% | Added |
| Captrust Financial Advisors | 1,500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Urban Wealth Management, LLC | 4,087 | $2.00K | 0.01% | +4,087 | New |
| Envestnet Asset Management Inc | 10,787 | $4.00K | 0.00% | +742+7.4% | Added |
| Virtu Financial LLC | 15,286 | $6.00K | 0.00% | +15,286 | New |
| State Street Corp | 20,270 | $8.00K | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 20,148 | $8.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 28,534 | $12.0K | 0.00% | +24,452+599.0% | Added |
| Rockwood Wealth Management, LLC | 30,101 | $12.6K | 0.01% | +11,500+61.8% | Added |
| UBS Group AG | 32,867 | $14.0K | 0.00% | +28,906+729.8% | Added |
| Northern Trust Corp | 50,176 | $21.0K | 0.00% | −4,218−7.8% | Reduced |
| Millennium Management LLC | 79,858 | $33.0K | 0.00% | +64,232+411.1% | Added |
| Two Sigma Advisers, LP | 84,700 | $35.0K | 0.00% | −27,600−24.6% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 110,500 | $46.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 158,747 | $66.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 361,395 | $151.0K | 0.00% | +126,949+54.1% | Added |
| Vanguard Group Inc | 583,853 | $243.0K | 0.00% | +32,579+5.9% | Added |
| IFP Advisors, Inc | 6 | – | – | −5−45.5% | Reduced |
| Kepos Capital LP | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −48,660−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −951−100.0% | Sold out |
| Tradewinds Capital Management, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |